Exploring the cost effectiveness of Mindfulness Based Cognitive Therapy for Cancer (MBCT-Ca)

INTERVENTION: The intervention group will receive an 8 week Mindfulness Based Cognitive Therapy for Cancer (MBCT‐Ca) course delivered in addition to usual treatment, whereas the control group will continue with their treatment as usual before receiving MBCT‐Ca after a wait period of approximately six months. CONDITION: Mental health of post‐treatment cancer patients ; Mental and Behavioural Disorders PRIMARY OUTCOME: The EQ‐5D (EuroQol, 1990) will provide the primary outcome measure of effect required to generate Quality Adjusted Life Years (QALYs) and the CSRI will provide the primary outcome measure of cost. These measures will be used to calculate the cost per QALY to determine the probability that MBCT‐Ca is cost‐effective. SECONDARY OUTCOME: 1. Number of eligible patients identified by the oncology teams; 2. Proportion of patients prepared to accept entry to the randomised pilot study; 3. Proportion considered appropriate for MBCT‐Ca after orientation by the course teacher; 4. Proportion of patients that complete the 8‐week course of MBCT‐Ca; 5. Proportion of patients returning completed forms at each time point up to 4 months after intervention; 6. Quantitative measure of quality of life and capabilities to include health related quality of life (HRQoL) assessed by EORTC‐QLQ‐QC30 and ICECAP‐A.; 7. Measure of anxiety and depression HADS; 8. Measure of participant wellbeing ‐ WHO‐5; 9. Self compassion short form (SCS‐SF); 10. Five Facet Mindfulness Scale short form (FFMS‐SF); 11. Teacher Competence Measure (MBI‐TAC) INCLUSION CRITERIA: 1. Adult patients (aged 18 years and over) who have received (or who are currently receiving) active cancer treatment including surgery, chemotherapy, radiotherapy, hormone therapy or a combination of these within the last 12 months 2. Patients able to attend the course venue weekly to undertake MBCT‐Ca